Sven Weiler

Sven Weiler is an accomplished professional in medicinal chemistry with extensive experience in the pharmaceutical industry. Currently serving as a Senior Expert in Drug Design Medicinal Chemistry at Pierre Fabre Group since April 2024, Sven previously held the position of Vice President of Medicinal Chemistry at Endogena Therapeutics, Inc. from August 2022 to December 2023. Prior roles include Head of Chemistry at Basilea Pharmaceutica Ltd from June 2016 to July 2022 and Executive Director/Unit Head of Medicinal Chemistry at Novartis between August 1999 and May 2016, where Sven also led a medicinal chemistry lab. Sven's academic background includes a degree in Synthetic Chemistry from Scripps Research, and degrees in Organic Chemistry from the University of Konstanz and Chemistry from The University of Freiburg. Expertise encompasses medicinal chemistry, synthetic organic chemistry, and project leadership.